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Several systems of cell surface antigens have now been recognized serologically on 
leukemia cells of the mouse (1). The technique that has played the major role in the 
detection  and  analysis  of these  antigenic  systems  is  the  cytotoxic test,  originally 
developed by Gofer and O'Gorman (2), in which target cells are lysed by specific antibody 
in the presence of a suitable source of  complement. Because antigens specified by the H-2 
complex are present on virtually all mouse cells, discovery of  other systems of  cell surface 
antigens depended on immune sera that were produced in H-2 compatible combinations 
or were rendered free of H-2 antibody by in vitro or in vivo absorption, or on serological 
test  procedures that eliminated  the  contribution of H-2  antibody.  In this way,  three 
general categories of cell surface antigens,  in addition to H-2,  have been serologically 
defined on leukemia cells (1). 
(a)  Differentiation alloantigens, e.g., Thy-1 and the Lyt series that signify the origin 
of the leukemia from precursors undergoing T-cell  differentiation in the thymic 
environment. 
(b)  Antigens of the TL  ~ (thymus-leukemia) series that occur either as differentiation 
alloantigens (TL  + leukemias occurring in TL  + strains of mice) or as a consequence 
of the derepression or activation of silent TL genes (TL  + leukemias occurring in 
TL- strains of mice). 
(c)  Murine  leukemia  virus  (MuLV)-related  antigens  that  owe  their  origin  to  the 
genome of endogenous viruses belonging to the MuLV family. The two antigens in 
this category that have been best defined serologically are the G(Gross) cell surface 
antigen (GCSA) and the G~ antigenic system, both of which have now been re- 
lated to structural components of MuLV. 
With the recognition that MuLV exists in a  highly polymorphic state in the 
mouse, it might be expected that this would be reflected in the existence of an 
extensive range of antigenically distinct MuLV-related cell surface antigens. In 
this  report  we  define by means of a  naturally occurring antibody present  in 
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normal mouse serum a new MuLV-related specificity, designated G(RADA1),  with 
properties that clearly distinguish it from GCSA and Gix. 
Materials  and  Methods 
Mice.  Random bred Swiss Ha/ICR mice were obtained from Millerton Farms (Millerton, N. 
Y.) or Charles River Breeding Laboratories (Wilmington, Mass.).  NZB/BINJ (=NZB) and RF/J 
mice were obtained from The Jackson Laboratory (Bar Harbor, Maine). All other mice came from 
our colonies. 
Antisera.  Preparation and reactivity of the polyvalent anti-MuLV serum ([W/Fu × BN]FL rat 
anti-MuLV-induced  W/Fu rat leukemia  [C58NT]D  [=anti-NTD])  and the GCSA typing serum 
(C57BL/6[ = C57BL] anti-AKR spontaneous leukemia K36) have been detailed elsewhere (3-5). 
Antisera against MuLV structural  proteins p15,  p30,  and gp70  were  made  according to the 
method of Fleissner et al.  (6).  Their specific reactivity was shown by radioimmunoprecipitation 
tests with 3H-amino acid-labeled MuLV proteins. 
Cells.  The A  strain leukemia, RADA1,  was induced by X-irradiation in 1962  and has been 
passaged in the ascites form in the strain of origin (7).  A description of the other transplantable 
tumor lines has been given in previous publications from our laboratory (5, 7-9). 
Complement  (C)-Dependent Cytotoxicity Test.  Equal volumes (50 pl) of target cells (5  x  10e/ 
ml), antiserum (serial dilutions), and appropriately diluted rabbit serum (C source) were mixed 
and incubated for 45 min at 37°C.  Viability counts were made in the presence of trypan blue. The 
diluent in all tests was medium 199 (Grand Island Biological Co., Grand Island, N.Y.). Preselected 
rabbit serum diluted  1:8 was used  in all tests with leukemia cells and at a  1:15  dilution with 
normal thymocytes. 
Qualitative  Absorption Test.  Antiserum  (dilution determined by preliminary cytotoxic tests) 
and washed, packed cells were mixed at a ratio of 2:1 and incubated for 30 rain at 4°C.  Generally, 
the dilution of antiserum used in absorption tests was two serial dilutions below its end point 
(50% cells lysed). After removing the absorbing cells by centrifugation at 900g, the supernate was 
tested for residual cytotoxic activity on the appropriate target cells (5, 10). 
Quantitative  Absorption  Test.  After  absorbing 50  /zl  of diluted  antiserum  with  a  range  of 
counted numbers of cells for 30 rain at 4°C,  the residual cytotexic activity of the absorbed serum 
for RADA1 cells was determined (4, 10). 
Induction of MuLV-Related Cell Surface Antigens by MuLV In Vitro.  G(aADAI,, GIX, and GCSA 
induction was assayed by the ability of MuLV-infected tissue culture cells to absorb cytotoxic 
activity from reference antisera  (10).  The cells used  for absorption were  confluent cultures of 
uninfected control cells or productively infected cells. Cultures were washed once with Ca ++ and 
Mg  ÷+ free phosphate-buffered saline and dispersed by incubation with 0.05% EDTA for 5 min at 
room temperature.  Cells were scraped from the surface of 100-mm Petri dishes and harvested by 
centrifugation at 500 g  and washed two times in Eagle's Minimal Essential Medium. After a final 
wash in medium 199, the cells were packed by slowly increasing the speed of centrifugation to 900 
g  over a  period of 10 min. 
Ecotropic viruses were propagated in mouse SC-1 cells; xenotropic and mink cell focus-inducing 
(MCF) viruses were propagated in mink (CCL64) cells.  The histories of the viruses studied are 
given in reference 10 and in the footnotes to Table III. 
Inhibition Tests with MuLV Proteins.  Individual MuLV proteins pl0, p12, p15, p30, and gp70 
were  purified  from  MuLV(Gross)  by  the  method  of Fleissner  (12)  and  resuspended  in  Tris- 
hydrochloride pH 7.6 at a concentration of 200 ~g/ml (Fig. 6 A) and 1,500/zg/ml (Fig. 6 B). Equal 
volumes (20 pl) of viral protein (serial dilutions) and 1:12.5 diluted antiserum (final dilution 1:25) 
were mixed and incubated for 30 min on ice. 50 ~l of a suspension of target cells (5 x  106/ml) was 
then added,  and incubation continued for 30 min on ice. The cells were washed once in 1.5 ml of 
medium 199,  resuspended in 100 ~tl of diluted C,  and incubated for 30 min at 37°C,  followed by 
viability counts in the presence of trypan blue (11). 
Immunoprecipitation  of  Labeled Membrane Proteins from Cell Lysates and L  ysed Virions.  The 
method of lactoperoxidase-catalyzed  radioiodination of viable cell  surface proteins  and  MuLV 
proteins has been described in detail elsewhere (11).  After lysis of cells with Nonidet P-40 (Shell 
Chemical Co.,  New  York),  immunoprecipitation of reactive labeled surface components from a 
lysate of 107 cells was accomplished with 20 ~tl of undiluted mouse antiserum and 500  ~zl of goat OBATA, STOCKERT, O'DONNELL,  OKUBO, SNYDER, AND  OLD 
90 
7O 
-~  5C 
3C 
AKSL2 
ASLI  ~  ERLD~I29RAD4 
L  ,  I  ,  I 
20  80  320 
I/Dilution  of Swiss  Ho/ICR serum 
1091 
FIG.  I.  Cytotoxic tests with a panel of  seven transplanted mouse leukemias. Demonstra- 
tion of  naturally occurring cytotoxic antibody in Swiss Ha/ICR mouse serum. 
anti-mouse Ig serum. Labeled polypeptides  in the immunoprecipitates were analyzed by poly- 
acrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and 2-mercaptoethanol in 
cylindrical gels (10 cm length, 7.5% acrylamide) for 3 h at 3 mA/gel, according to the method of 
Laemmli (13). 
Results 
Serological Definition  of the  G(RADA1  ) Antigen.  The  G(RADAI  )  system  was 
detected during a survey of normal mouse sera for naturally occurring cytotoxic 
antibody to leukemia cells.  A  proportion  of random  bred Swiss Ha/ICR mice 
were found to have such antibody,  and  sera from mice with the highest titer 
were  individually  tested  on  a  panel  of transplanted  leukemia  lines.  Fig.  1 
illustrates  a  test with seven leukemias and shows that  the  Swiss serum has 
strong cytotoxic reactivity with AKSL2, a spontaneous leukemia of AKR origin, 
and RADA1, an A strain leukemia originally induced by X-ray. Reactivity was 
intermediate  with  EJG2,  a  leukemia  induced  by passage  A  Gross  virus  in 
C57BL mice, and K36, a  spontaneous leukemia of AKR origin.  No cytotoxicity 
was  observed with  ASL1,  an  A  strain  spontaneous  leukemia  or  ERLD  and 
129RAD4,  two X-ray-induced leukemias of C57BL or 129 origin,  respectively. 
Absorption tests with RADA1 as the target cell were consistent with the results 
of direct  cytotoxic tests  (Fig.  2);  RADA1,  E$ G2,  AKSL2,  and  K36  absorbed 
reactivity,  whereas  ERLD,  ASL1, and  129RAD4  failed  to  do  so.  This  result 
indicated that E SG2, AKSL2, and K36, although differing in their sensitivity 
to  the  Swiss  cytotoxic  antibody,  nevertheless  shared  the  same  antigen  or 
spectrum  of antigens  with  RADA1.  Further  absorption tests with AKSL2 or 
E c;G2  rather  than  RADA1 as the  target  cells confirmed  this conclusion  and 
suggested  the  detection  of a  single  antigenic  system.  Because  the  surface 
phenotype of this leukemia panel is well defined, it was also possible to conclude 
that the antigen detected by the Swiss serum was serologically unrelated to any 1092  G(RADA1 )  CELL  SURFACE  ANTIGEN  OF  MURINE  LEUKEMIA 
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FIG. 2.  Qualitative absorption tests  to determine the specificity  of naturally occurring 
cytotoxic  antibody for  RADA1  target  cells  in Swiss Ha/ICR serum. The absorption capacity 
of  these seven leukemias parallels  their  sensitivity  to the Swiss natural antibody in direct 
cytotoxic  tests  (see  Fig. I). 
previously defined cell surface alloantigen or MuLV-related antigen. Participa- 
tion of known alloantigens is excluded by the fact that ASL1, which shares all 
known A strain alloantigenic systems with RADA1 (H-2, TL, Lyt series, Thy-1), 
is not lysed by the Swiss  serum,  nor can it remove cytotoxic reactivity for 
RADA1  in absorption tests.  The new specificity is also unrelated to the two 
MuLV-related cell surface antigens, GCSA and G~x, because RADA1 lacks the 
GCSA  determinant,  and  129RAD4, which  is  G~x  +,  lacks  the  determinant 
detected by the Swiss serum. 
RADA1  was chosen as the prototype target cell  in subsequent analysis of  the 
system. As the RADA1  antigen was found to  bear a close  relation  to MuLV  (see 
below), it was named GCRADAI )  in conformity with our precedent of  designating 
MuLV-related  cell  surface antigens G  for Ludwik Gross who discovered this 
class  of  viruses. 
Presence of G ~RADA ~) in Normal and Preleukemic Tissues 
Absorption tests indicated that normal thymocytes  of 2-mo-old AKR mice ex- 
pressed G~DA,, even though these cells were not lysed by anti-GcRADAI~  sera in 
direct cytotoxic tests.  For this reason, the distribution of G<aADAI~ in normal 
tissues was investigated by absorption procedures. 
TISSUE DISTRIBUTION OF  G(RADA1  ) IN  NORMAL  AKR  MICE.  Qualitative absorp- 
tion tests detected G~RADAI~ in the thymus, spleen, bone marrow, lymph nodes, 
and  liver of 2-too-old  AKR mice.  Brain,  red blood  cells,  and  kidney typed 
G(RADAI)-.  Quantitative absorption analysis showed that spleen cells  expressed 
higher levels  of  G(RADA1 ) than other lymphoid or hematopoietic AKR  cells;  bone OBATA,  STOCKERT,  O'DONNELL,  OKUBO,  SNYDER,  AND  OLD  1093 
90 
7c 
~  5C  ........ 
~g3c 
.io 
~  lo 
o 
I  IL  II  ,  I  I  /  ,  , 
3.6  ~2 B.7  |S.3 
lO'%Number  of cells used for obsorption 
FIO.  3.  Quantitative  absorption tests for G~a^vA~ expression on cells from spleen (Spl), 
bone marrow (BM),  lymph nodes (LN), and thymus (Thy) of 2-mD-old AKR female mice. 
Arrow  (J,)  indicates numbers of cells that  reduce the cytotoxic activity of the  diluted 
GOnADAl1  typing serum to 50% RADA1 lysis. The quantity of G~,XDA~ is greatest on spleen 
cells, intermediate on bone marrow and lymph node cells, and least on thymocytes. 
marrow and lymph node cells were found to have approximately two-thirds the 
G(RADA1) quantity of spleen cells, and thymocytes approximately one-fifth the 
quantity (Fig. 3). This pattern of G<aADAI~ in the tissues of young AKR mice is 
similar to the distribution of Gix and GCSA, the two previously recognized cell 
surface antigens related to naturally occurring MuLV (1, 4, 5). 
STRAIN DISTRIBUTION OF G(RADA1  ).  AS spleen was the richest source ofG(RADA1 ) 
in normal AKR mice, other mouse strains were typed for G~RADA1) by absorption 
tests with normal spleen. Table I summarizes the strain distribution of G<aADAX~ 
in  relation to the  G~x  and  GCSA  phenotype of these  mice.  From this,  the 
following conclusions can be drawn: 
(a)  High leukemia-incidence  strains, e.g., AKR, C58, C3H/Figge, and AKR-H-T are 
G~RADA1,  +. The spleens of these strains also type Gxx +GCSA  +. 
(b)  Low leukemia-incidence  strains, e.g., A,  C57BL, and BALB/c are  G~RAI)AI)-. In 
these strains, G~SADAI~ cannot be detected by absorption tests in any normal tissue. 
(c)  The C3Hf/Bi strain is referred to as a conversion strain because it undergoes a C~x- 
GCSA- --* G[x +GCSA  + change in the lymphoid tissues between 2 and 6 mo of age, 
and this antigenic conversion is associated with MuLV production  (14). G~RAD^I) 
shows a similar pattern in C3Hf/Bi mice, being absent in 2-too-old  mice but present 
at 6 mo of age. 
(d)  In this survey of inbred strains, GCRADAt  ) was never found in the absence of GCSA 
and G1x. However, GCSA  and Gix can be expressed in the absence of  G(RADA1 ) .  For 
example,  4-  to  6-too-old  NZB  mice  type  GCSA+GIx  +  but  G~DA1)---  (The 
Grx+GCSA-G~RAVAI~  - phenotype is characteristic of many low leukemia-incidence 
strains, e.g., 129, A, etc. In these strains, lymphoid tissues other than thymus do 
not express G~x, and this contrasts with the presence of Gix in all lymphatic tissues 
of G[x + high leukemia-incidence  mice [4].) 
(e)  Both G~aADAI) and Gix  are  expressed  in F,  hybrids of AKR with other mouse 
strains. F1 expression of GCSA, however, depends in most instances on the Fv-1 1094  G(RADA1 )  CELL  SURFACE  ANTIGEN  OF  MURINE  LEUKEMIA 
TABLE  I 
Occurrence of G<RAD~ in the Spleen of lnbred and Hybrid Mice: Relation to G Ix and 
GCSA Phenotypes* 
GIRADAII  ÷  G~RADA],- 
G,x+GCSA  +  G~+GCSA  G,x+GCSA  +  G,x+GCSA  -  Gm-GCSA 
Inbred mice: 
AKR, AKR/TI 
AKR-H.2  b 
C58 
C3H/Figge 
C3Hf/Bi (old)$ 
NZB (old)$  A  129-Gix 
129  C57BL 
C57BL-GIx  +  C57BR 
C57BL-G~x+M  C57L 
C57BR-G~*M  BALB/c 
I  CBA/T6 
DBA/2  C3HtTBi (young)~: 
SJL/J  RF 
C3H/An  HSFS/N 
NZB (young)$ 
Hybrid mice:  Random bred mice 
AKR x C3Hf/Bi§  AKR x CBA/T6  Swiss Ha/ICR 
C57L × AKR  AKR × RF 
C57BL x AKR 
* G,~,,,~ and GCSA typing by absorption tests with spleen cells; G~ typing by almorption tests with thymocytes. 
Conversion strains (lee text). 
|  Reciprocal cross tested. 
allele contributed by the low leukemia strain partner (1). (Fv-1 alleles control the 
consequence  of infection  by MuLV by permitting or restricting viral replication 
and dissemination [15]. Matings ofAKR [genotype Fv-1 '~] with other Fv-1  n strains, 
e.g.,  C3Hf/Bi  or  C57L produce  GCSA ÷ hybrids,  whereas  matings  with  Fv-1  b 
strains, e.g., C57BL or with the Fv-1  nr RF strain [W. P. Rowe, personal communi- 
cation] produce GCSA- hybrids. The notable exception to this rule is the GCSA- 
phenotype of AKR hybrids with  CBA/T6,  an  Fv-l"  strain;  see reference  1 for 
discussion.)  Thus, the G,x ÷ G<RAOAI~  ÷ GCSA- phenotype, which is not seen in any 
of the parental inbred strains, is unique for hybrids. 
PRELEUKEMIC  AMPLIFICATION  OF  G(RADA1  )  EXPRESSION  IN  AKR  THY- 
MUS.  Thymocytes of AKR mice undergo age-related changes in expression of 
H-2 and Thy-1 alloantigens and MuLV-related antigens such as Gix and GCSA 
(16).  In  contrast  to the  high  Thy-1/low H-2,  G~x, GCSA surface phenotype of 
thymocytes of 2-too-old AKR mice,  thymocytes from 6-mo-old AKR mice fre- 
quently exhibit  a  low Thy-1/high  H-2,  G~x, GCSA phenotype.  This change  is 
not  associated  with  increased  production  of ecotropic  MuLV,  but  correlates 
closely with the emergence of MuLV with the capacity to grow on mink cells 
(17,  18). As illustrated in Fig. 4, the expression of G~RADAI~ is also amplified in 6- 
mo-old AKR thymocytes. Parallel tests for G,x  and for G(RADA1  )  on  thymocytes 
from individual AKR donors showed that G,x  amplification invariably accom- 
panies GC,  ADA~ amplification but that Glx can be amplified without amplification 
of GCRADAI~, once again  indicating  that expression of these two MuLV-related 
traits is under separate control. 
G(RADAl)Pher~otype of Tumor Cells.  A survey of the G(RADAI),  GL~, and GCSA 
phenotypes  of over  15  transplanted  mouse  tumors  is  given  in  Table  II.  As 
expected,  the  two  transplanted  leukemias  (K36  and  AKSL2)  arising  in  the 
G(RADAI)  +  AKR  strain were  G(RADAI)  + as were  ii primary  AKR  leukemias. 
G¢RADAI) + tumors occur also  in GCRADAI)- strains (e.g.,  RADA1,  Ec~G2, Meth 4), 
just as GIx  +GCSA + tumors arise in GIx-GCSA-  strains. Typing for G1x and OBATA,  STOCKERT,  O'DONNELL,  OKUBO,  SNYDER,  AND  OLD  1095  9oI  
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represents a cytotoxic test with G(a^vA1) typing serum and thymocytes from an individual 
AKR mouse. Dashed line represents cytotoxic tests with thymocytes from 31 6-too-old AKR 
mice showing no  amplification  in  G(aAVA1) expression.  (Thymocytes  from  2-too-old AKR 
mice are not sensitive to G(aAD^I) antibody in direct cytotoxic tests, but by absorption tests 
can be shown to express G(~D^I).) 
G(RADA1  ) were  generally concordant; no  G~-G(RADA1)  + tumor was found but two 
Gxx+G(RADAI)  -  leukemias were. The GCSA phenotype was also generally con- 
cordant with the  GIx/G{RADAI  )  phenotype. However, tumors with exceptional 
Grx/G(aADA1)/GCSA phenotypes have been found, e.g., RADA1, RL~ 1,  MOPC- 
70A, and 129RAD4. 
Induction of G(RADA1  )  by MuLV Infection.  Analysis of the G(RADAI)  system 
revealed several close parallels with the G~ and GCSA systems. G~, GCSA, 
and G(aADA1  ) occur together in the normal tissues of high leukemia-incidence 
strains, show amplified expression in thymus of 6-mo-old AKR mice, and appear 
in the leukemias and solid tumors of strains whose normal tissues lack these 
antigens.  These  similarities  suggest  that  G(aADAI), like  G~  and  GCSA,  is 
specified by  MuLV genes.  As  shown  in  Table  HI,  G(RADA1  )  is  expressed by 
permissive cells after in vitro infection by certain isolates of MuLV. G(RADA1) 
was induced by four of five N-tropic MuLV and by one of four B-tropic MuLV 
isolates. MuLV with the capacity to infect cells of heterelogous species but not 
cells  of the  mouse  (xenotropic  MuLV)  do  not  induce  G(RADAI), and  this  is 
consistent with the observation that the tissues of NZB mice, a  strain that 
naturally produces  high  levels  of xenotropic  MuLV  throughout  life,  types 
G(RADAI  )-  (Table I).  The prototype MCF MuLV,  MCF 247, a  virus that is be- 
lieved to  have arisen by a  recombinational event between an  N-tropic  and 
xenotropic MuLV (18-20), behaves like an N-tropic MuLV rather than a xeno- 
tropic MuLV with regard to G(RADA1  ) induction. A new MCF isolate, AKR MCF 
69L1, also behaves in this fashion. 1096  G(RADA1  )  CELL  SURFACE  ANT]~GEN  OF  MURINE  LEUKEMIA 
TABLE  II 
G lx, G(R,4DA1), and GCSA Phenotypes of Transplanted Tumors of the Mouse 
Strain of  ori-  Method of  tumor induction  Tumor 
gin  and type 
MuLV-related cell  surface 
antigens 
Gix  G~RADAI  )  GCSA 
In vivo 
RADA1  A 
ASL1  A 
Ec? G2  C57BL 
ERLD  C57BL 
EL4  C57BL 
Meth A  BALB/c 
RLc~ 1  BALB/c 
MOPC-70A  BALB/c 
K36  AKR 
AKSL2  AKR 
129RAD4  129 
129"GIx-RAD17  129-G~- 
In vitro 
Meth 4  C57BL "] 
B6MS2  C57BL | 
m 
Meth A(s)*  BALB/c I 
Meth A(a)*  BALB/c | 
CMS3  BALB/c ] 
CMS4  BALBIc  l 
CMS5  BALB/cJ 
X-ray leukemia  +  +  - 
Spontaneous  leukemia  -  -  - 
MuLV-Grose  leukemia  +  +  + 
X-ray leukemia  -  -  - 
DMBA  leukemia  -  -  - 
Methylcholanthrene  sarcoma  -  -  - 
X-ray  leukemia  +  -  + 
Mineral oil myeloma  -  -  + 
Spontaneous leukemia  +  +  + 
Spontaneous leukemia  +  +  + 
X-ray leukemia  +  -  - 
X-ray  leukemia  -  -  - 
Methylcholanthrene sarcoma 
+  +  + 
+  +  + 
+  +  + 
+  +  + 
*  Meth  A(s)  and Meth A(a) refer  to cell  lines  derived from the parental Meth A sarcoma (s)  and 
the ascites  variant derived from it (a);  see reference  9. 
In this  series  of  tests,  no dissociation  between Gix and G~RADAI)  typing was 
observed;  MuLV  induced either  the GIX+G(RADA1) + or the GIx-G(RADAI)- pheno- 
type. No MuLV  was found that caused expression of G~x in the absence of 
G(RADAI  ) and GCSA, a surface  phenotype that is found in vivo  on thymocytes 
(Table I) and on tumor cells  (Table  II).  GCSA is a general marker for  MuLV 
replication,  with both N- and B-tropic  MuLV  and xenotropic  MuLV  (with  the 
exception  of  AT124) inducing this  antigen in  permissive cells  (10). 
Relation of GcRADAI~  to Structural Components of MuL  V 
CYTOTOXIC  TESTS WITH  ANTI-MuLV-COMPONENT  SERA.  Fig.  5 shows cytotoxic 
tests  with RADA1  cells  and heterologous  antisera  to MuLV-structural compo- 
nents.  RADA1 is  lysed  by  two anti-gp70  sera (anti-MuLV[AKR] gp70  and anti- 
MuLV[Scripps] gp70) known to have broad gp70 reactivity  (E. Fleissner, 
unpublished data),  but not by a type-specific  gp70 antisera  prepared against 
MuLV(Rauscher)  gp70. Antisera to the p15 and p30 core components of 
MuLV(AKR) and MuLV(Rauscher) were not  cytotoxic  for  RADA1. This  finding 
is consistent  with the GCSA- phenotype of  RADA1.  (GCSA is related  to the 
internal core  proteins of MuLV, p15, and p30, which occur  as glycosylated 
polyproteins  on the surface  of  infected  cells  [11].  For this  reason,  anti-p15  and 
anti-p30  lyse  GCSA + cells  but not GCSA- cells  [1]). 
ABSORPTION  TESTS  WITH  MuLV  STRUCTURAL  COMPONENTS.  The  cytotoxic 
reactivity of anti-gp70 sera with RADA1 could be directed against the G[x-gp70 TABLE  Ill 
Induction of G ix, G(RADA1), and GCSA after Infection by MuL V 
MuLV  Host range 
MuLV-induced cell surface antigens* 
Gix  Gc~wl~  GCSA 
WN1802N CLB5 
WN1802B CLD1 
B6(N) CLA3 
B6-7(B) CLD3 
B6Mai-10(B)$ 
BALB:N.3§ 
BALB:B.6§ 
AKR-L1 CLG12 
AKR 69E~[ 
Moloney CLH6 
Rauscher CL1 
Ecotropic: 
N-tropic 
B-tropzc 
N-tropic 
B-tropic 
B-tropic 
N-tropic 
B-tropic 
N-tropic 
N-tro ~Ic 
NB-tro dc 
NB-troplc 
++  ++  ++ 
_  --  ++ 
++  ++  ++ 
++  ++  + 
_  _  ++ 
_  -  ++ 
_  --  ++ 
++  ++  ++ 
++  ++  ++ 
w  -  + 
S16CLI  0  (I)  Xenotropic  -  -  + 
AT124  Xenotropic  -  -  - 
NZB  Xenotropic  -  -  + 
AKR 69X~1  Xenotropic  -  -  + 
AKR MCF 247¶  Dualtropic  + +  + +  + + 
AKR MCF 69L1"*  Dualtropic  + +  + +  + + 
* G~x, G(RADAI),  and GCSA  typing by absorption tests  (see  Materials and Methods and reference 
10). + +, complete absorption; +, partial  absorption; and -, no absorption  of  cytotoxic reactiv- 
ity from appropriately diluted typing sera. 
$ Isolated  from  pooled  spleen, lymph node, and thymus tissue  of  a 12-too-old  C57BL/6 Mai mouse 
(J. W. Hartley, personal communication). 
§ Isolated from the spleen of  a 16-too-old  BALB/c mouse (P. V. O'Donnell, unpublished data). 
II  Cloned viruses isolated  from the thymus of  a 6-too-old  AKR  mouse (2169)  exhibiting  amplified 
expression of  MuLV  antigens (P. V. O'Donnell, E. Steckert, and L. J. Old, unpublished data). 
¶ Reference 18. 
** Isolated from a 5-too-old  leukemic AKR  mouse injected intrathymically at 2 mo of  age with 
culture fluid from mink cells  co-cultured with AKR  2169 thymus tissue (J. A. Lewis, P. V. 
O'Donnell, E. Stockert, and L. J. Old, unpublished data). 
.•70 
inti-MuLV(AKR) g 
~  5O 
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N  3O 
TO  40  160  640  2560 
]/Dilution  of antiserum 
Fro.  5.  Cytotoxic tests with RADA1 target cells and heteroantibody to MuLV(Scripps), 
MuLV(AKR),  and MuLV(Rauscher)  structural  components.  Antibody to  MuLV(Scripps) 
gpT0 and MuLV(AKR)  gp70 cytotoxic for RADA1  cells. 
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/.Lg viral protein used for  obsorption 
Fro. 6.  (A) and (B) Two absorption tests  with isolated  MuLV(Gross) structural  compo- 
nents. RADA1  typing serum (diluted  according to end point)  is absorbed with graded 
quantities  of  viral  protein  and  tested  for  residual  cytotoxic  antibody against RADA1 cells. 
X  = percent RADA1 lysed  by unabsorbed anti-G<a^D^,  serum (diluted  1:25).  Absorption  of 
anti-G<aADA,  reactivity  is  seen with MuLV(Grose) gp70. 
expressed by RADA1 or against other gp70 cell surface molecules, possibly a 
gp70 with GmADA~) determinants. To investigate the relation of GmADA~ to gp70 
more  directly,  purified  MuLV  structural  components were  tested  for  their 
capacity to absorb GmADA, antibody from the Swiss typing serum (Fig. 6 A and 
B). Whereas MuLV(Gross) pl0, p12, plS, and 1030 removed virtually no cytotoxic 
activity, MuLV(Gross) gp70 absorbs anti'GmADA1)  reactivity in a dose-dependent 
fashion. 
IMMUNOPP0gCIPITATION  TESTS  WITH  RADIOLAEELED  MuLV.  The  presence  of 
antibody to gp70 in the GmADA1) typing serum was shown in experiments in- 
volving precipitation  of [~H]amino  acid-  or  [3H]glucosamine-labeled compo- 
nents of MuLV(Gross) by anti'G~zADA, serum and goat anti-mouse immuno- 
globulin serum. The only MuLV component precipitated by G(RADAI  ) antiserum 
was gp70. 
IMMUNOPRECIPITATION TESTS  WITH RADIOLABELED RADA1  CELLS.  The surface 
molecules carrying  GmADA1) determinants were  characterized  by  enzymatic 
radioiodinization of viable  RADA1  cells,  precipitation with  GmADA, typing 
serum, and analysis by polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulfate.  An electropherogram of the proteins precipitated by 
anti-GmA,A~) serum  is  shown in  Fig.  7A.  Two  major protein  species were 
observed.  One species co-electrophoresed with an MuLV(Gross) gp70 marker 
and  was  shown  to  be  a  glycoprotein  by  the  galactose  oxidase-sodium- 
[3H]borohydride method of labeling surface glycoproteins (21). The other spe- 
cies, designated "a",  is a  nonspecifically precipitated protein which has been 
identified as actin by its selective precipitation with anti-actin serum (H.  W. 
Snyder, Jr., unpublished data). The precipitating activity of anti'GmADAl~ serum 
for the 70,000 dalton species on RADA1 cells was not removed after absorption 
with a  GmADA,- cell population (thymocytes from C57BL-G~x  + mice), but was OBATA,  STOCKERT,  O'DONNELL,  OKUBO,  SNYDER,  AND  OLD  1099 
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FIG.  7.  Co-electrophoresis  of [SH]glucosamine-labeled  MuLV(Gross)  gp70 (O) with 12~I- 
labeled surface proteins of  RADA1  leukemia cells  (0) precipitated from a cell  lysate with: 
(A) unabsorbed  Swiss G~RADAI  ~  typing serum  (=anti-G~aADA1~); (B) anti-G~RADAI  ~  absorbed 
with C57BL-G~x + thymocytes  (a G(RADAI  )- cell  population); (C) anti-G~RAVA1  )  absorbed with 
RADA1  leukemia cells;  (D) Swiss mouse serum lacking G~RADAI  )  antibody. 
removed by  absorption  with  RADA1  leukemia  cells  (Fig.  7B  and  C).  No 
molecule of this size class was precipitated by the anti-G<~ADA, serum from 
comparably labeled A strain thymocytes and ASL1 leukemia cells; this fmding 
is consistent with the G~aADA,- phenotype of these two A strain cells. 
Occurrence of Cytotoxic Antibody for RADA1 Cells in Normal Mouse Serum. 
A  preliminary survey of 25  inbred and hybrid strains  of mice showed that 
naturally  occurring cytotoxic antibody for  RADA1  cells  is  not restricted to 
random-bred Swiss  mice  (Table  IV).  High  titered  sera  were  also  found in 
individual C57BL, A, BALB/c, and C57BL hybrid mice. Cytotoxic (C57BL  × 
A)F1 sera were selected for specificity tests by absorption analysis; reactivity for 
G~RADAI~ was  shown  to  be  identical  to  reference  Swiss  serum.  Sera  with 
reactivity against RADA1 cells were also tested for naturally occurring Gxx 
antibody. As reported previously, anti-Gix is found in F~ hybrids resulting from 
C57BL and C57BL-GIx + x  129 matings, but not in the parental inbred strains 
(22). Parallel tests of sera from individual mice showed that G~x  and RADA1 
reactivity were clearly separable. 
Discussion 
With the description  of  the G~RAVA1) antigen, four  systems of  MuLV-related 
cell surface antigens detected  by mouse antibody can now be distinguished. 
Three of  these  (GCSA, Gg, and G~RADAI))  are specified  by naturally  occurring 1100  O(RADA1  )  CELL  SURFACE  ANTIGEN  OF  MURINE  LEUKEMIA 
TABLE  IV 
Occurrence of Natural Cytotoxic Antibody for RADA1 Cells in Mice of Various 
Genotypes* 
Strain 
Total num- 
ber of  mice 
tested 
Cytetoxic  test  (% RADAI  lysed) 
~95  94-75  74-50  49-15  <15 
Number of mice 
Swiss Ha/ICR  82  6  1  6  6  63 
129  8  8 
129-Glx-  5  5 
C57BL  20  3  3  1  1  12 
C57BL-G~x  +  17  1  1  1  2  12 
C57BL-Grx+M  14  2  (2)*  2  (2)  1  9 
C57BR  8  5  3 
C57BR-GIx+M  8  4  4 
C57L  8  2  6 
C58  4  4 
AKR  12  12 
AKR-H-2  b  10  2  6  2 
DBA/2  9  1  1  7 
C3Hf/Bi  6  1  3  2 
A  8  1  7 
BALB/c  10  1  8  1 
SJL/J  4  4 
HSFS/N  6  6 
HRS/J  9  2  7 
NZB  23  4  5  14 
C57BL  x  129-GLx-  39  1  15  23 
C57BL-G~ +  ×  129  32  2  (2)  9  (6)  15  6 
C57BL  x  A  18  3  4  3  5  3 
C57BL-TL  +  ×  A  21  3  (1)  2  5  11 
C57BL  x  A-TL-  21  2  2  1  6  10 
NZB  x  NZW  31  1  (1)  1  8  21 
* Serum was collected  from  6-  to  12-mo-old  mice,  diluted  i:i0,  and tested  individually  for  cytotoxic 
activity against RADA1  cells.  All sera with reactivity against RADA1  cells  (>50% RADA1 
lysed)  were also  tested  for naturally occurring Gr~ antibody in cytotoxic  tests  with C57BL-G~  + 
thymocytes (Glx+G~s^D^1,  - target cells)  and C57BL thymocytes (GIx-GcRADAI)-  target cells). 
Numbers in parentheses refer  to proportion of  mice with Grx antibody in addition  to cytotoxic 
RADA1  antibody. 
endogenous MuLV  (I),  and the other,  the Friend,  Moloney and Rauscher (FMR) 
complex (23),  occurs  only on cells  after  exogenous infection  with FMR  viruses. 
We are currently  analyzing three additional  antigens belonging to  this  general 
category of  cell  surface  molecules and there is  reason  to  expect that  the list  will 
continue to  grow. A nomenclature, comparable to  the one adopted  for  structural 
components of MuLV  and other oncornaviruses (24),  that would relate  these 
cell  surface  antigens to  MuLV  proteins  would be  highly desirable,  and the  basis 
for  such  a nomenclature has  begun with  the  demonstration that  G~x and  G(RADAI ) 
are related to gp70 molecules (25,  26) and that GCSA  is related to internal 
virion  components, p15 and p30  of  MuLV  (11).  However, until  agreement can  be 
reached on an appropriate nomenclature,  we propose that new cell  surface 
specificities  related  to  endogenous MuLV  follow  the G<RADAI~  convention;  G, as a OBATA, STOCKERT, O'DONNELL,  OKUBO, SNYDER,  AND  OLD  1101 
TABLE V 
Gix ,  G~RADAI~, and GCSA Phenotypes of Mouse Lymphoid Cells in Vivo and MuLV- 
Infected Cells in Vitro 
Phenotype  Occurrence in vivo  In vitro  induction by MuLV 
Gxx+G~aAvA~+GCSA ÷  Normal  lymphoid tissues and leuke-  Permissive cells  infected by 
mias  of  high  leukemia-incidence  certain ecotropic MuLV 
strains (e.g.,  AKR,  C58) that are  and by AKR  MCF  247 and 
overt,  life-long  producers of  MuLV  69L1 
GIx-G~aAI)AI)+GCSA + 
GIx+G¢RADAI)-GCSA + 
Not found  Not found 
BALB/c  RLdl  (a BALB/c  leukemia  Not found 
induced by X-ray) 
Grx+G~aADAI~+GCSA  RADAI  (an  A strain  leukemia induced  Not found 
by X-ray) 
G[x-GcRAI)AI,-GCSA  + 
GIx-G~RAOAI,-GCSA- 
Leukemias  induced by FMR  viruses 
(but otherwise not found in normal 
lymphoid tissues  or in spontaneous 
leukemias or leukemias induced by 
X-ray  or  chemicals);  observed  in 
MOPC-70A  (a BALB/c myeloma in- 
duced by mineral oil) 
Normal thymocytes of low leukemia- 
incidence G[x- strains  (e.g., C57BL, 
BALB/c) 
Permissive cells infected by 
most B-tropic MuLV, FMR 
MuLV,  and  most xeno- 
tropic MuLV 
Permissive cells  infected by 
AT124 xenotropic MuLV 
GIX+G~RADAI~-GCSA  -  Normal thymocytes of low leukemia-  Not found 
incidence G~x  + strains (e.g.,  129,  A 
strain) 
GIx-G~aAD^I~+GCSA  -  Not found  Not found 
generic term for naturally occurring MuLV, in honor of Ludwik Gross who dis- 
covered murine leukemia viruses, followed by the designation of the prototype 
normal or malignant  cell, e.g.,  RADA1 used in the definition of the antigenic 
system.  In  this  light,  GCSA  would now be renamed  G~E~G2~ and  Grx  would 
become G~ngt) (t  =  normal  thymocytes).  Clearly,  GCSA and G~ are no longer 
appropriate designations; the term GCSA could refer to all cell surface antigens 
related to endogenous MuLV, and the original basis for naming Grx, the assign- 
ment of a gene specifying G~ to the IX linkage group of the mouse (4), we now 
know to be incorrect because the apparent relationship between G~ and linkage 
group IX is one of pseudo- or quasilinkage and not true linkage  (27).  However, 
because of the widespread use of both the GCSA and G~x terminology, it would 
seem inadvisable to propose changing  the designation of these two MuLV-re- 
lated antigens until a  definitive nomenclature can be established. 
Table  V  lists  the  eight  possible G~x, G~RADA,, and  GCSA  phenotypes and 
examples of their occurrence on normal and malignant lymphoid cells in vivo or 
on permissive cells aider MuLV infection in vitro. Two in vivo phenotypes have 
never been observed,  and  this  relates  to the  fact that  G~aADA, has  not been 1102  G(RADA1  )  CELL  SURFACE  ANTIGEN  OF  MURINE  LEUKEMIA 
found on cells lacking the G,x  trait.  G,x,  in contrast,  can be expressed in the 
absence  of G(aADA,,  and  the  best  example  of this  is  its  occurrence  on  the 
thymocytes of certain low leukemia-incidence strains,  such as 129 or A  strain 
mice.  Present evidence indicates  that  both Gtx  and  G(RADA,) are type-specific 
determinants present on gp70 molecules of certain MuLV, and that in the case 
of the prototype G,  aADA,~ + leukemia RADA1, both antigens reside on the same 
gp70  molecule.  Taken  together,  this  information  might  suggest  that  MuLV 
induction  assays  would  reveal  three  of  four  possible  G,x/G~DA,)  surface 
phenotypes  (the  absent  one,  G~-G~RADA,+). Only  two  were  actually  found 
(G~-G~RADAI( and  G~+G~aADA,+); the  MuLV  isolates  we  examined  coded for 
either both antigens or neither.  Attempts are currently underway to isolate a 
G,x +G~aADA,-  -- inducing MuLV variant from leukemia cells having this pheno- 
type (e.g., BALB/c RLd 1). 
A  characteristic  of G~x, G~RADA,~, and  GCSA is their  appearance  in sponta- 
neous or X-ray-induced leukemias of mouse strains that lack these antigens in 
their normal tissues, and this can be attributed to the derepression or activation 
of endogenous  MuLV  either  as  a  cause  or  consequence  of leukemogenesis. 
Whereas  the  genes  for  Gtx  and  GCSA  appear  to  be  ubiquitous  in  mice,  as 
indicated  by  the  occurrence  of GIx+GCSA  +  leukemias  and  solid  tumors  in 
varying  numbers  in  the  mouse  strains  tested,  too few tumors  have  been 
examined  to  draw  the  same  conclusion  for  GCRADA,~" However,  the  strain 
distribution of antibody to G~RADAI~  would suggest that G(RADAI) genetic informa- 
tion is widespread in the mouse population.  An important  consequence of the 
activation of G,x,  G(RADA,~, and  GCSA genes in malignant  cells of strains  not 
normally expressing these antigens is that these new surface components could 
serve  as  tumor-specific  antigens.  The  fact  that  mice  can  recognize  these 
endogenous MuLV-related cell surface antigens as foreign under certain circum- 
stances and form demonstrable antibody raises the possibility that such immune 
reactions may have an important, if not determining, role in the spread of virus 
in the infected host and in the emergence of transformed cells. If appearance of 
GmADA,) is  a  consistent feature  of X-ray-induced leukemias  in  certain  mouse 
strains,  it will be of interest to know whether the incidence of these leukemias 
might  be  reduced  by GmADA,~ antibody,  acquired  by either  passive or  active 
immunization. 
Three additional systems of cell surface antigens related to MuLV have now 
been detected by our laboratory using naturally occurring mouse antibody, and 
these  await  detailed  analysis.  The  expectation  is  that  the  array  of diverse 
MuLV-related cell  surface  antigens  will parallel  the  array of distinct  MuLV 
types that  exist  in  the  mouse.  Current  evidence  points  to the  fact  that  the 
MuLV family is remarkably polymorphic. The source of this extensive variation 
is unknown,  but clearly recombinational  events between classes of MuLV or 
between MuLV and host genes provide ample opportunity for an almost endless 
range of MuLV variants to arise. These recombinants could be generated during 
the lifetime of the host or have arisen in a distant ancestor and then be fixed in 
the  strain  as  a  consequence  of stable  integration.  The  array  of cell  surface 
antigens coded for by these MuLV variants may turn out to be vast and could 
explain the perplexing  diversity of transplantation  antigens  found on chemi- OBATA,  STOCKERT,  O'DONNELL,  OKUBO,  SNYDER,  AND  OLD  1103 
cally induced tumors and other tumor types of the mouse (9).  Because each of 
these antigens appears to be unique for individual tumors and shows no cross 
reaction with any other tumor, it was considered unlikely that MuLV could be 
responsible  for  such  antigenic  variation.  With  the  awareness  that  MuLV 
polymorphism may be equally diverse, this possibility will have to be reconsid- 
ered. 
Summary 
A  new cell  surface  antigenic  system of the  mouse,  designated  G~RADAI~, is 
described.  The antigen  is defined by cytotoxic tests with the A  strain  X-ray- 
induced leukemia RADA1 and naturally occurring antibody from random-bred 
Swiss mice and can be distinguished  from all other serologically detected cell 
surface antigens of the mouse. Absorption tests indicate that G~RADAI~  is present 
in  the  normal  lymphatic  tissue  and  leukemias  of mouse  strains  with  high 
spontaneous leukemia-incidence,  e.g.,  AKR, C58,  and C3H/Figge.  Low leuke- 
mia-incidence  strains,  e.g.,  C57BL/6,  BALB/c,  and  A  lack  G~RADAI~ in  their 
normal tissues, but a proportion of leukemias and solid tumors arising in these 
strains  are  G~aADAI~  +.  The  relation  of G~RADA~ to  MuLV  is  shown  by G~RADA~ 
appearance  after MuLV infection of permissive  cells in vitro;  four of five N- 
tropic MuLV isolates, one of four B-tropic MuLV, and none of four xenotropic 
MuLV induce  G<RADA*~. Two MCF MuLV,  thought  to represent  recombinants 
between N-ecotropic  and  xenotropic  MuLV,  also induce  G~RADA~. Serological 
and  biochemical  characterization  indicates  that  G<RADAI~ is  a  type-specific 
determinant of the gp70 component of certain MuLV. The presence of natural 
antibody to RADA1 in  various mouse strains  and  the emergence of G~RADA~  + 
leukemias and solid tumors in mice of G~RADA~- phenotype suggest widespread 
occurrence of genetic information coding for this antigen. 
We thank Doctors E. Fleissner, W. D. Hardy, Jr., and S. J. Kennel for their gifts of anti-MuLV 
antisera,  Dr.  A.  B.  DeLeo  for providing cultured  lines of mouse  sarcomas,  and  Miss D.  R. 
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